Psychopharmacology journal

Your access to a leading psychopharmacology journal

When you want to access the latest clinical psychiatry news and psychopharmacology research, Psychiatrist.com offers peer-reviewed articles and evidence-based content drawn from leading psychopharmacology journals.

On Psychiatrist.com, you’ll find comprehensive access to the most up-to-date psychiatry information and research in psychopharmacology. Psychiatrist.com also offers the latest cognition research and research on diagnosis and treatment of a wide range of behavioral health and neuropsychiatric disorders.

In coordination with the CME Institute, Psychiatrist.com also provides access to CME activities where you can earn AMA PRA Category 1 Credits™ on a schedule that works for you.

To explore all the benefits and research from psychopharmacology journals that Psychiatrist.com has to offer, simply register for free or subscribe today.

View peer-reviewed articles and research

You’ll find a rich collection of psychopharmacology data and research on Psychiatrist.com. The website includes material collected from two sources. The Journal of Clinical Psychiatry (JCP) is a leading psychiatric rehabilitation journal and psychopharmacology journal that is among the 10 most-cited journals in the field. The Primary Care Companion for CNS Disorders (PCC) is a psychiatry journal that’s dedicated to advancing the clinical expertise of primary care physicians and other clinicians who treat patients with mental and neurologic illnesses.

Content on the website includes psychopharmacology journal articles such as:

Psychopharmacology

Explore Topic

Satisfy CME requirements at your convenience

Psychiatrist.com offers a broad assortment of more than 150 CME activities drawn from psychiatry research journal articles and psychopharmacology journal research. CME activities are provided by the CME Institute (CMEInstitute.com), which is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

When you register on Psychiatrist.com, you’ll have access to MyCME, a free online tool from the CME Institute that keeps a record of your activity on the website. With your MyCME account, you can easily start an activity at any time and return to finish it later. You can also complete posttests and evaluations and print transcripts and certificates of the credits you’ve earned.

CME activities related to psychopharmacology journal articles include:

FAQs on accessing content from a premier psychopharmacology journal

Yes. To participate in CME activities on Psychiatrist.com, you must be a registered user on the website. Registration is free and provides a host of other benefits as well.

There is no charge for nearly all CME activities on Psychiatrist.com. Occasionally, you may encounter a $10 processing fee on certain activities.

In the ASCP Corner section of Psychiatrist.com, you’ll find a large collection of brief peer-reviewed, evidence-based psychopharmacology journal articles.

Yes. JCP offers online-only and combined online/print subscriptions. Visit the JCP subscription page for details and pricing.

Register or subscribe to access content from a top psychopharmacology journal

When you register for free as a user on Psychiatrist.com, you’ll have access to a wealth of psychopharmacology journal articles as well as research on many other topics in psychiatry and mental health. Your registration lets you view the full text of all articles and supplements from The Primary Care Companion as well as the full text of supplements and certain free articles from The Journal of Clinical Psychiatry. As a registered user, you can participate in over 150 CME activities and sign up for Elerts that provide you with daily email alerts about new psychopharmacology journal articles, research, reports, and studies hosted on the website.

For complete access to all articles and research on Psychiatrist.com, you’ll need a subscription to JCP. As a subscriber, you can access all current and archived content published in JCP from 1997 to the present. You’ll also have online access to new issues of the journal on the day they are released, as well as articles published in JCP Weekly.

Podcasts provide highlights of journal articles

To stay on top of the latest psychopharmacology journal articles, subscribe to podcasts from Psychiatrist.com. Each podcast features a 15- to 25-minute audio summary of each issue of JCP or PCC. You’ll get an overview of the research and highlights of the findings from each article, allowing you to identify the articles you wish to return to later for deeper study. Podcasts offer an easy and convenient way to keep up to date on the latest developments in the field of psychopharmacology.

About Psychiatrist.com

Psychiatrist.com is a digital publication of Physicians Postgraduate Press, Inc. The website provides clinicians with access to a rich collection of articles, news, research, and educational materials from three sources: The Journal of Clinical Psychiatry (a leading psychiatry research journal), The Primary Care Companion for CNS Disorders, and the CME Institute at CMEInstitute.com.

As a leader among psychiatry and psychiatric rehabilitation journals, Psychiatrist.com provides up-to-date information for psychiatrists and mental health professionals as well as primary care physicians and other clinicians who treat patients with mental illness. Content on Psychiatrist.com covers a broad range of subjects, including signs of ADHD in adults and ADHD symptoms in children; the latest strategies for treating dementia; diagnosis of schizotypal personality disorder; symptoms of moderate major depressive disorder; research on unipolar major depressive disorder; and information about many other behavioral health and neuropsychiatric disorders.

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original research

Utility and Barriers to Clozapine Use: A Joint Study of Clinicians’ Attitudes From Singapore and Hong Kong

This survey investigated clinicians’ use of clozapine for schizophrenia, beliefs about its effectiveness, and concerns regarding this...

Read More...